Cara Therapeutics
CARA
#4943
Rank
$0.51 B
Marketcap
$9.60
Share price
3.67%
Change (1 day)
-33.93%
Change (1 year)

Revenue for Cara Therapeutics (CARA)

Revenue in 2022 (TTM): $0.02 B

According to Cara Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.02 B. In 2020 the company made a revenue of $0.13 B an increase over the years 2019 revenue that were of $0.01 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cara Therapeutics from 2014 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$0.02 B
2020$0.13 B579.28%
2019$0.01 B
2014$3.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$94.88 B 366,472.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$92.36 B 356,763.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.37 M-98.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.07 B 191.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.10 B 287.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.12 B 374.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.74 M-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA